Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
anti-ICAD, mAb (AF41E3)
Product Details | |
---|---|
Synonyms | H13; DFF1; ICAD; DFFA; DFF-45; Inhibitor of CAD; DNA Fragmentation Factor Subunit α; DNA Fragmentation Factor 45 kDa Subunit |
Product Type | Monoclonal Antibody |
Properties | |
Clone | AF41E3 |
Isotype | Mouse IgG2a κ |
Immunogen/Antigen | Recombinant human His-ICAD protein purified from E. coli. |
Application |
ELISA |
Crossreactivity | Human |
Purity Detail | Ammonium sulfate precipitation. |
Formulation | Liquid. HEPES with 0.15M NaCl, 0.01% BSA, 0.03% sodium azide, and 50% glycerol. |
Isotype Negative Control | |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Declaration | Manufactured by AbFrontier |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Use/Stability | Stable for at least 1 year after receipt when stored at -20°C. |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet |
![]() |
The inhibitor of caspase-3-activated DNase (ICAD) is a caspase 3 substrate that controls nuclear apoptosis. ICAD has two isoforms: a functional isoform of 45kDa, ICAD-L/DNA fragmentation factor (DFF) 45; and a 35kDa isoform, ICAD-S/DFF35. Although both ICAD-L and ICAD-S can bind and inhibit CAD, only ICAD-L was reported to be functional. ICAD is cleaved to be inactivated and allow caspase-activated DNase (CAD) to execute nuclear internucleosomal apoptotic DNA fragmentation. In non-apoptotic cells, CAD is complexed with its inhibitor, ICAD. The activation of the CAD/ICAD complex occurs through the caspase 3-mediated cleavage of ICAD at residues 117 and 224, which results in three ICAD fragments that are then released from CAD. In addition to its DNase inhibitory activity, ICAD acts as a CAD specific folding chaperone. There are recent reports that ICAD is a potential target for restoring a normal apoptotic signal transduction pathway in colon and brain cancer cells. Inhibitor of the caspase-activated DNase (DFF40).
1) Enari M et al, Nature. (1998) vol.391(6662): pp.43-50. (General)
2) Sakahira H et al, J Biol Chem. (1999) vol.274(22): p.15740-4. (General)
3) Charrier L et al, Cancer Res. (2002) vol.62(7): p.2169-74. (General)
4) Fukushima K et al, J Mol Biol. (2002) vol.321(2): p.317-27. (General)